Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1
Contributors
Balakrishna, Suraj; Loosli, Tom; Zaheri, Maryam; Frischknecht, Paul; Huber, Michael; Kusejko, KatharinaPublished in
The journal of antimicrobial chemotherapy, vol. 78, no. 3, p. 656-664Publication date
2023-03First online date
2023-02-04Abstract
Keywords
- Male
- Humans
- HIV-1
- HIV Infections / drug therapy
- Cohort Studies
- Drug Resistance, Viral / genetics
- Viral Load
- HIV Seropositivity / drug therapy
- Mutation
- High-Throughput Nucleotide Sequencing / methods
- Genotype
- Anti-HIV Agents / therapeutic use
UNIGE affiliation entities
UNIGE research groups
Funding
- Swiss National Science Foundation - Swiss HIV Cohort Study (SHCS) [177499]
- Swiss National Science Foundation - HIV-1 Transmission in Switzerland: viral transmission traits, superinfection and drug resistance [179571]
- Swiss National Science Foundation - HIV-1 integration sites and their impact on HIV-1 pathogenesis [141067]
- Swiss National Science Foundation - The Evolutionary Epidemiology of HIV Elimination [207957]
- Swiss National Science Foundation - Using transmission networks for assessing and guiding prevention efforts in hiv [155851]
Citation (ISO format)
BALAKRISHNA, Suraj et al. Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1. In: The journal of antimicrobial chemotherapy, 2023, vol. 78, n° 3, p. 656–664. doi: 10.1093/jac/dkac430
Main files (1)
Article (Published version)
Secondary files (1)
Supplemental data - Figures S1 to S4 and Tables S1 to S5
Identifiers
- PID : unige:176154
- DOI : 10.1093/jac/dkac430
- PMID : 36738248
